Researchers are pursuing new treatment approaches to treating advanced gliomas in instances where chemotherapy and radiation are not effective.
In pediatrics, clinical outcomes from primary brain tumors remain inferior to other cancers. Neurooncologist Neha Patel, MD, discusses game changing advances leading to targeted treatments.
This novel CED device promises larger volume of drug distribution than with prior CED devices. Early human testing in glioma patients supports that hope, and use in other CNS conditions is being explored.